Dr. Sven Jansen received the Healthcare Innovation Leadership Award at the 2025 Fluxx Awards in Hong Kong, celebrating his contributions to digital diagnostics and enhancing patient access in healthcare systems.
With a PhD in molecular medicine from Harvard Medical School and the University of Bremen, Dr. Jansen has held key positions at GE Healthcare, CSC, and Booz & Company. He currently leads Neo Q and Medivise Healthcare.
Dr. Jansen developed guided reporting solutions that integrate AI findings into clinical reports, boosting speed by over 40% and easing clinicians’ administrative tasks.
“Our goal is to complement, not replace, clinical expertise,” said Dr. Jansen. “Technology should minimize obstacles, enabling professionals to concentrate on patient care.”
These solutions are rapidly gaining traction in Europe and the Middle East, offering culturally adapted, multilingual reports that are accessible to patients.
Dr. Jansen also prioritizes integrating telemedicine in primary care, allowing remote clinician contributions while upholding quality standards, meeting rising demands and limited healthcare resources.
“Healthcare needs to adapt to modern demands,” stated Dr. Jansen. “Today’s patients want to actively participate, influencing when, where, how, and with whom their care is managed.”
Dr. Jansen co-authored the white paper “Sustainability in Radiology,” exploring how reporting systems can lessen the environmental impact of medical imaging, which accounts for over 5% of global healthcare emissions.
